Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
暂无分享,去创建一个
[1] M. Toruner,et al. NF‐κB Signaling , 2006 .
[2] M. Daucher,et al. Activation of the serum response factor by p65/NF‐kappaB. , 1996, The EMBO journal.
[3] D. Schwartz,et al. Toll-like receptors in the pathogenesis of human disease , 2004, Nature Immunology.
[4] Zhijian J. Chen,et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.
[5] R. Gaynor,et al. Regulation of IκB Kinase (IKK)γ/NEMO Function by IKKβ-mediated Phosphorylation* , 2002, The Journal of Biological Chemistry.
[6] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[7] D. Wallach,et al. If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation. , 2006, Molecular cell.
[8] Y. Xiong,et al. A Role for NF-κB Essential Modifier/IκB Kinase-γ (NEMO/IKKγ) Ubiquitination in the Activation of the IκB Kinase Complex by Tumor Necrosis Factor-α* , 2003, Journal of Biological Chemistry.
[9] G. Nabel,et al. A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation. , 1993, The EMBO journal.
[10] H. Erdjument-Bromage,et al. IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.
[11] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[12] J. Inoue,et al. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins. , 1993, Oncogene.
[13] M. Merville,et al. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .
[14] C. Mirtsos,et al. The Role of Interleukin 1 Receptor-associated Kinase-4 (IRAK-4) Kinase Activity in IRAK-4-mediated Signaling* , 2004, Journal of Biological Chemistry.
[15] Michael Karin,et al. Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .
[16] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[17] B. Williams,et al. Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.
[18] Richard A. Young,et al. Insights into host responses against pathogens from transcriptional profiling , 2005, Nature Reviews Microbiology.
[19] S. Miyamoto,et al. Expanded Nuclear Roles for IκBs , 2004, Science's STKE.
[20] H. Kuwata,et al. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. , 2006, Immunity.
[21] A. Baldwin,et al. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.
[22] Douglas K. Miller,et al. The Interleukin-1 Receptor-associated Kinase Is Degraded by Proteasomes following Its Phosphorylation* , 1997, The Journal of Biological Chemistry.
[23] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[24] Y. You,et al. Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation* , 2006, Journal of Biological Chemistry.
[25] W C Greene,et al. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.
[26] Y. Kadono,et al. Segregation of TRAF6‐mediated signaling pathways clarifies its role in osteoclastogenesis , 2001, The EMBO journal.
[27] S. Akira,et al. Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.
[28] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[29] Leonard Buckbinder,et al. NF-κB RelA Phosphorylation Regulates RelA Acetylation , 2005, Molecular and Cellular Biology.
[30] K. Ishii,et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling , 2006, Nature Immunology.
[31] S. Ghosh,et al. Regulating Inducible Transcription Through Controlled Localization , 2005, Science's STKE.
[32] E. Reinherz,et al. Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor , 2002 .
[33] S. Gerondakis,et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.
[34] Fan Yang,et al. IKKβ Plays an Essential Role in the Phosphorylation of RelA/p65 on Serine 536 Induced by Lipopolysaccharide1 , 2003, The Journal of Immunology.
[35] S. Akira,et al. Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.
[36] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[37] H. Erdjument-Bromage,et al. The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.
[38] H. Sakurai,et al. TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism. , 1998, Biochemical and biophysical research communications.
[39] P. Dobrzanski,et al. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. , 1995, Oncogene.
[40] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[41] L. Cantley,et al. The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.
[42] Michael Karin,et al. Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.
[43] M. Hardy,et al. The Murine Irak2 Gene Encodes Four Alternatively Spliced Isoforms, Two of Which Are Inhibitory* , 2004, Journal of Biological Chemistry.
[44] M. May. A Nuclear Factor in B Cells and Beyond , 2006, The Journal of Immunology.
[45] S. Akira,et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.
[46] S. Ghosh,et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .
[47] Toby Lawrence,et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.
[48] B. Lemaître,et al. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. , 2001, Genes & development.
[49] W. Tam,et al. Cytoplasmic Sequestration of Rel Proteins by IκBα Requires CRM1-Dependent Nuclear Export , 2000, Molecular and Cellular Biology.
[50] E. Dejardin. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. , 2006, Biochemical pharmacology.
[51] Joshua M. Korn,et al. The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.
[52] Ash A. Alizadeh,et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] Sankar Ghosh,et al. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.
[54] A. Bowie,et al. The human adaptor SARM negatively regulates adaptor protein TRIF–dependent Toll-like receptor signaling , 2006, Nature Immunology.
[55] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[56] S. Srinivasula,et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.
[57] E. Lander,et al. Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] Zhijian J. Chen,et al. Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.
[59] R. Tibbetts,et al. Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.
[60] Takahiro Doi,et al. Tumor Necrosis Factor-α-induced IKK Phosphorylation of NF-κB p65 on Serine 536 Is Mediated through the TRAF2, TRAF5, and TAK1 Signaling Pathway* , 2003, Journal of Biological Chemistry.
[61] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[62] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[63] S. Akira,et al. TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.
[64] G Cantarella,et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.
[65] J. Orange,et al. Interleukin-1-induced NF-κB Activation Is NEMO-dependent but Does Not Require IKKβ* , 2007, Journal of Biological Chemistry.
[66] Alexander Hoffmann,et al. Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.
[67] A. Shevchenko,et al. Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit , 2004, Science.
[68] G. Mosialos,et al. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. , 1993, Oncogene.
[69] A. Baldwin,et al. Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529* , 1998, The Journal of Biological Chemistry.
[70] K. N. Pennington,et al. In Vivo Identification of Inducible Phosphoacceptors in the IKKγ/NEMO Subunit of Human IκB Kinase* , 2003, Journal of Biological Chemistry.
[71] Jiahuai Han,et al. Limiting inflammatory responses during activation of innate immunity , 2005, Nature Immunology.
[72] T. Maniatis,et al. Immune Activation of NF-κB and JNK Requires Drosophila TAK1* , 2003, Journal of Biological Chemistry.
[73] Zhijian J. Chen,et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.
[74] S. Ghosh,et al. The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .
[75] W. Greene,et al. p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.
[76] S. Dower,et al. Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit* , 1997, The Journal of Biological Chemistry.
[77] Alexander Hoffmann,et al. IκBɛ provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression , 2006, The Journal of cell biology.
[78] Tak W. Mak,et al. Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β , 2004 .
[79] Daniel R. Caffrey,et al. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.
[80] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[81] W. Greene,et al. Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.
[82] W. Liao,et al. NFκB Interacts with Serum Amyloid A3 Enhancer Factor to Synergistically Activate Mouse Serum Amyloid A3 Gene Transcription* , 2000, The Journal of Biological Chemistry.
[83] S. Akira,et al. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-α production in macrophages , 2003 .
[84] Inder M. Verma,et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1) , 2005 .
[85] B. Seed,et al. RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.
[86] C. Ambrosino,et al. Regulation of HIV-1 Long Terminal Repeats by Interaction of C/EBP(NF-IL6) and NF-κB/Rel Transcription Factors* , 1996, The Journal of Biological Chemistry.
[87] A. Hoffmann,et al. Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors , 2005, Cell.
[88] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[89] Eric Verdin,et al. Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.
[90] W. Greene,et al. A novel NF-kappa B complex containing p65 homodimers: implications for transcriptional control at the level of subunit dimerization , 1993, Molecular and cellular biology.
[91] C. Sardet,et al. Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65* , 2003, The Journal of Biological Chemistry.
[92] Govinda Rao,et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.
[93] P. Cohen,et al. TAB3, a new binding partner of the protein kinase TAK1. , 2004, The Biochemical journal.
[94] N. Perkins. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.
[95] J. Knop,et al. Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.
[96] R. Gaynor,et al. Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling , 2003, The EMBO journal.
[97] J. Stavnezer,et al. Interaction of Stat6 and NF-κB: Direct Association and Synergistic Activation of Interleukin-4-Induced Transcription , 1998, Molecular and Cellular Biology.
[98] K. Burns,et al. Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.
[99] Ki-Young Lee,et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. , 2005, Genes & development.
[100] J. Inoue,et al. Cutting Edge: TNFR-Associated Factor (TRAF) 6 Is Essential for MyD88-Dependent Pathway but Not Toll/IL-1 Receptor Domain-Containing Adaptor-Inducing IFN-β (TRIF)-Dependent Pathway in TLR Signaling1 , 2004, Journal of Immunology.
[101] J. Casanova,et al. IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness* , 2004, Journal of Biological Chemistry.
[102] G. Stark,et al. Mutant Cells That Do Not Respond to Interleukin-1 (IL-1) Reveal a Novel Role for IL-1 Receptor-Associated Kinase , 1999, Molecular and Cellular Biology.
[103] T. Muta. IκB‐ζ: An Inducible Regulator of Nuclear Factor‐κB , 2006 .
[104] G. Nabel,et al. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation , 1994, Molecular and cellular biology.
[105] W. Greene,et al. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.
[106] D. Baltimore,et al. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. , 1989, Genes & development.
[107] S. Westerheide,et al. Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II* , 2000, The Journal of Biological Chemistry.
[108] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[109] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[110] H. Young,et al. BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages* , 2004, Journal of Biological Chemistry.
[111] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[112] S. Miyamoto,et al. Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress , 2003, Cell.
[113] J. Ninomiya-Tsuji,et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.
[114] S. Ruben,et al. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.
[115] S. Gerondakis,et al. Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[116] G. Courtois,et al. Posttranslational modifications of NEMO and its partners in NF-κB signaling , 2006 .
[117] C. Jefferies,et al. Interferon Regulatory Factor-3-mediated Activation of the Interferon-sensitive Response Element by Toll-like receptor (TLR) 4 but Not TLR3 Requires the p65 Subunit of NF-κ* , 2003, Journal of Biological Chemistry.
[118] J. Swantek,et al. IL-1 Receptor-Associated Kinase Modulates Host Responsiveness to Endotoxin1 , 2000, The Journal of Immunology.
[119] S. Saccani,et al. Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB Response , 2004, The Journal of experimental medicine.
[120] F. Kashanchi,et al. Enhancement of Nuclear Factor-κB Acetylation by Coactivator p300 and HIV-1 Tat Proteins* , 2002, The Journal of Biological Chemistry.
[121] A. Israël,et al. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .
[122] Gerard J. Nau,et al. Cumulative Toll-Like Receptor Activation in Human Macrophages Treated with Whole Bacteria1 , 2003, The Journal of Immunology.
[123] H. Sakurai,et al. IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.